Can propranolol prevent progression of melanoma?

Jason Kao, Brent Luu

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


The worldwide incidence of melanoma has risen rapidly in the past 50 years and is a considerable public health burden in the United States, with significant financial implications. Studies have demonstrated the potential anticarcinogenic effects of antihypertensive agents, specifically beta-blockers, in patients with prostate cancer, breast cancer, and lately cutaneous malignant melanoma. This article explores the empirical clinical evidence of propranolol's anticarcinogenic effects on melanoma and the chemoprotective mechanisms of beta-blockers and other agents that have been used to modify melanoma progression.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalJAAPA : official journal of the American Academy of Physician Assistants
Issue number6
StatePublished - Jun 1 2019

ASJC Scopus subject areas

  • Nurse Assisting


Dive into the research topics of 'Can propranolol prevent progression of melanoma?'. Together they form a unique fingerprint.

Cite this